Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells

Mammalian Genome

Volumn 12, Issue 10, 2001, Pages 772-778

  Zhou, Li ^a   Rowley, Daniel L ^a   Mi, Qing Sheng ^a   Sefcovic, Natasha ^a   Matthes, Hans W D ^b   Kieffer, Brigitte L ^b   Donovan, David M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MU OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; BEHAVIOR; DNA SEQUENCE; EMBRYO; EMBRYO CELL; EXON; GENE LOCUS; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; INTRON; MOUSE; MOUSE STRAIN; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; STEM CELL; STRAIN DIFFERENCE;

ALLELES; ANIMALS; BASE SEQUENCE; EMBRYO; GENE FREQUENCY; GENE TARGETING; GENETIC VECTORS; GENOME; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU; RECOMBINATION, GENETIC; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; STEM CELLS;

ANIMALIA; MURINAE; RODENTIA;

EID: 0034812709     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-001-1003-8     Document Type: Article

References (86)

1. Interaction between mismatch repair and genetic recombination in Saccharomyces cerevisiae
2. Opiate receptors in mice: Genetic differences
3. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain
4. Genealogies of mouse inbred strains
5. A single-nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling
6. Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice
7. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains
8. The human genome project - An overview
9. A study of oral morphine preference in inbred mouse strains
10. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains
11. Most classical Mus musculus domesticus laboratory mouse strains carry a Mus musculus musculus Y chromosome
12. Targeting of exogenous DNA into Trypanosoma brucei requires a high degree of homology between donor and target DNA
13. List of transgenic and knockout mice: Behavioral profiles
14. Single-nucleotide polymorphism in the human mu opioid receptor gene alters B-endorphin binding and activity: Possible implications for opiate addiction
15. Genotype and test experience determine responsiveness to morphine
16. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
17. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies
18. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
19. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus
20. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
21. Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells
22. Genetically determined differences in the effects of morphine on mice
23. Evolution in inbred strains of mice appears rapid
24. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy
25. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured in positron emission tomography
26. Dependence of frequency of HR on the homology length
27. Pharmacogenetic evidence for the involvement of serotonin-1B (5-HT 1B) receptors in the mediation of morphine analgesic sensitivity
28. The length of homology required for gene targeting in embryonic stem cells
29. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells
30. Targeted mutagenesis of the murine opioid system
31. Morphine analgesia, tolerance and dependence in mice from different strains and vendors
32. Towards new models of disease and physiology in the neurosciences: The role of induced and naturally occurring mutations
33. Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G-protein coupling
34. Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination
35. Targeted disruption of the MHC class II Aa gene in C57bL/6 mice
36. Intronic sequences are involved in neural targeting of human dopamine transporter gene expression
37. Posttranscriptinal regulation of gene expression in liver regeneration: Role of mRNA stability
38. Establishment of a germ-line competent C57BL/6 embryonic stem cell line
39. Mu opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
40. Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
41. Interspecies gene exchange in bacteria: The role of SOS and mismatch repair systems in evolution of species
42. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
43. Protein binding to simple repetitive sequences depends on DNA secondary structure(s)
44. The genetic mediation of individual differences in sensitivity to pain and its inhibition
45. Transgenic studies of pain
46. Pain genes? Natural variation and transgenic mutants
47. Analgesic, locomotor and lethal effects of morphine in the mouse: Strain comparisons
48. Influence of DNA sequence identity on efficiency of targeted gene replacement
49. The origin of common laboratory mice
50. Familiar typical migraine. Linkage to chromosome 19p13 and evidence for genetic heterogeneity
51. Identification and characterization of three new alternatively spliced mu-opoid receptor isoforms
52. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F
53. Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania
54. Genetic basis of migraine
55. Opiate receptor binding sites in human brain
56. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants
57. Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice
58. Retention of heroin and morphine-6B-glucuronide analgesia in a new line of mice lacking exon1 of the MOR-1
59. Mismatch correction acts as a barrier to homeologous recombination in Saccharomyces cerevisiae
60. Single-nucleotide polymorphisms can cause different structural folds of mRNA
61. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
62. An improved protocol to increase sensitivity of Southern blot using dig-labelled DNA probes
63. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia
64. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
65. The short 3′-end region of complementary DNAs as PCR-based polymorphic markers for an expression map of the mouse genome
66. Dissection of behavior and psychiatric disorders using the mouse as a model
67. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells
68. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs
69. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
70. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells
71. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain
72. Altered hematopoiesis, behavior, and sexual function in mu opiod receptor-deficient mice
73. Longitudinal genetic analysis of menstrual flow, pain and limitation in a sample of Australian twins
74. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
75. The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses
76. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors
77. Examination of the involvement of supraspinal and spinal mu on delta opioid receptors in analgesia using the mu receptor deficient CSBK mouse
78. Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology
79. Animal models for pain research
80. Human mu opiate receptor. CDNA and genomic clones, pharmacologic characterization and chromosomal assignment
81. Mouse genetics/genomics: An effective approach for drug target discovery and validation
82. Migraine in twins raised together and apart
83. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells